Ascendis Pharma A/S (ASND)
NASDAQ: ASND · IEX Real-Time Price · USD
122.85
+1.78 (1.47%)
May 21, 2024, 4:00 PM EDT - Market closed

Ascendis Pharma Revenue

Ascendis Pharma had revenue of $357.63M in the twelve months ending March 31, 2024, with 322.18% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $104.23M with 185.49% year-over-year growth. In the year 2023, Ascendis Pharma had annual revenue of $296.35M with 444.36% growth.

Revenue (ttm)
$357.63M
Revenue Growth
+322.18%
P/S Ratio
19.45
Revenue / Employee
$406,864
Employees
879
Market Cap
6.96B USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023296.35M241.91M444.36%
Dec 31, 202254.44M45.60M515.94%
Dec 31, 20218.84M359.37K4.24%
Dec 31, 20208.48M-6.55M-43.58%
Dec 31, 201915.03M2.87M23.57%
Dec 31, 201812.16M10.33M562.40%
Dec 31, 20171.84M-3.01M-62.12%
Dec 31, 20164.85M-3.97M-45.02%
Dec 31, 20158.82M-8.10M-47.89%
Dec 31, 201416.92M-11.15M-39.71%
Dec 31, 201328.06M7.51M36.53%
Dec 31, 201220.56M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.32B
The Ensign Group 3.85B
Jazz Pharmaceuticals 3.84B
Masimo 1.98B
Penumbra 1.10B
HealthEquity 999.59M
Intra-Cellular Therapies 513.93M
Blueprint Medicines 282.21M
Revenue Rankings